RECURSION PHARMACEUTICALS, INC. (41) | Change of Control Agreements (2)
- Executive Change in Control and Severance Plan (for executives other than the CEO) (Filed With SEC on March 22, 2021)
- CEO Executive Change in Control and Severance Plan (Filed With SEC on March 22, 2021)
